Latest insights in therapeutic options for systemic right ventricular failure: A comparison with left ventricular failure

Heart

Volumn 95, Issue 12, 2009, Pages 960-963

  Winter, M M ^a   Bouma, B J ^a   Groenink, M ^a   Konings, T C ^b   Tijssen, J G P ^a   Van Veldhuisen, D J ^c   Mulder, Barbara J M ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CARVEDILOL; DIURETIC AGENT; ENALAPRIL; LOSARTAN; RAMIPRIL;

ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; GREAT VESSELS TRANSPOSITION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; HYPERVOLEMIA; MEDICAL DECISION MAKING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; THORAX SURGERY;

ADRENERGIC ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HEART FAILURE; HUMANS; PACEMAKER, ARTIFICIAL; TRANSPOSITION OF GREAT VESSELS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 67649195747     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.156265     Document Type: Review

References (40)

1. Mustard WT. Succesful two-stage correction of transposition of the great vessels. Surgery 1964;55:469-472
2. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J 2004;25:1264-1270 (Pubitemid 38891578)
3. Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007;115:163-172 (Pubitemid 46105714)
4. Lundstrom U, Bull C, Wyse RK, et al. The natural and " unnatural" history of congenitally corrected transposition. Am J Cardiol 1990;65:1222-1229 (Pubitemid 20160940)
5. Becker AE, Anderson RH. How should we describe hearts in which the aorta is connected to the right ventricle and the pulmonary trunk to the left ventricle? Am J Cardiol 1983;51:911-912
6. Hornung TS, Bernard EJ, Jaeggi ET, et al. Myocardial perfusion defects and associated systemic ventricular dysfunction in congenitally corrected transposition of the great arteries. Heart 1998;80:322-326 (Pubitemid 28470759)
7. Fratz S, Hauser M, Bengel FM, et al. Myocardial scars determined by delayed-enhancement magnetic resonance imaging and positron emission tomography are not common in right ventricles with systemic function in long-term follow up. Heart 2006;92:1673-1677 (Pubitemid 44629185)
8. Hauser M, Bengel FM, Hager A, et al. Impaired myocardial blood flow and coronary flow reserve of the anatomical right systemic ventricle in patients with congenitally corrected transposition of the great arteries. Heart 2003;89:1231-1235 (Pubitemid 37164022)
9. Chow PC, Liang XC, Cheung EW, et al. New two-dimensional global longitudinal strain and strain rate imaging for assessment of systemic right ventricular function. Heart 2008;94:855-859 (Pubitemid 351914693)
10. Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997;29:194-201. (Pubitemid 27028739)
11. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-99 (Pubitemid 34747447)
12. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERITHF). Lancet 1999;353:2001-2007.
13. Hall SA, Cigarroa CG, Marcoux L, et al. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 1995;25:1154-1161
14. Bristow MR, Ginsburg R, Umans V, et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor downregulation in heart failure. Circ Res 1986;59:297-309. (Pubitemid 17178124)
15. Doughan AR, McConnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol 2007;99:704-706 (Pubitemid 46273313)
16. Josephson CB, Howlett JG, Jackson SD, et al. A case series of systemic right ventricular dysfunction post atrial switch for simple D-transposition of the great arteries: the impact of beta-blockade. Can J Cardiol 2006;22:769-772 (Pubitemid 44227473)
17. Lindenfeld J, Keller K, Campbell DN, et al. Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries. J Heart Lung Transplant 2003;22:198-201. (Pubitemid 36173679)
18. Giardini A, Lovato L, Donti A, et al. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. Int J Cardiol 2006; Jun 10 [Epub ahead of print].
19. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
20. Dore A, Houde C, Chan KL, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 2005;112:2411-2416 (Pubitemid 41504490)
21. Hechter SJ, Fredriksen PM, Liu P, et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol 2001;87:660-3, A11. (Pubitemid 32178472)
22. Robinson B, Heise CT, Moore JW, et al. Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol 2002;23:618-623 (Pubitemid 36927826)
23. Therrien J, Provost Y, Harrison J, et al. Effect of angiotensin receptor blockade on systemic right ventricular function and size: A small, randomized, placebo-controlled study. Int J Cardiol 2008.
24. Lester SJ, McElhinney DB, Viloria E, et al. Effects of losartan in patients with a systematically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol 2001;88:1314-1316 (Pubitemid 33132106)
25. Urata H, Healy B, Stewart RW, et al. Angiotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metab 1989;69:54-66. (Pubitemid 19172427)
26. Perez-Calvo J, Civeira F, Ferrando J, et al. The effects of enalapril on exercise capacity and right ventricular function in patients with chronic cor pulmonale. An Med Interna 2000;17:527-532 (Pubitemid 30840690)
27. Bayliss J, Norell M, Canepa-Anson R, et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987;57:17-22. (Pubitemid 17216948)
28. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717
29. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853 (Pubitemid 34603028)
30. Diller GP, Okonko D, Uebing A, et al. Cardiac resynchronization therapy for adult congenital heart disease patients with a systemic right ventricle: analysis of feasibility and review of early experience. Europace 2006;8:267-272 (Pubitemid 43905733)
31. Walsh EP. Interventional electrophysiology in patients with congenital heart disease. Circulation 2007;115:3224-3234 (Pubitemid 47018141)
32. Triedman JK. Arrhythmias in adults with congenital heart disease. Heart 2002;87:383-389 (Pubitemid 34270958)
33. Alexander ME, Cecchin F, Walsh EP, et al. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004;15:72-76 (Pubitemid 38147223)
34. Van Son JA, Danielson GK, Huhta JC, et al. Late results of systemic atrioventricular valve replacement in corrected transposition. J Thorac Cardiovasc Surg 1995;109:642-652
35. Imai Y, Sawatari K, Hoshino S, et al. Ventricular function after anatomic repair in patients with atrioventricular discordance. J Thorac Cardiovasc Surg 1994;107:1272-1283 (Pubitemid 24149895)
36. Mee RB. Severe right ventricular failure after Mustard or Senning operation. Twostage repair: pulmonary artery banding and switch. J Thorac Cardiovasc Surg 1986;92:385-390 (Pubitemid 16021171)
37. Poirier NC, Yu JH, Brizard CP, et al. Long-term results of left ventricular reconditioning and anatomic correction for systemic right ventricular dysfunction after atrial switch procedures. J Thorac Cardiovasc Surg 2004;127:975-981 (Pubitemid 38451929)
38. Daebritz SH, Tiete AR, Sachweh JS, et al. Systemic right ventricular failure after atrial switch operation: midterm results of conversion into an arterial switch. Ann Thorac Surg 2001;71:1255-1259 (Pubitemid 32328683)
39. Smith L, Farroni J, Baillie BR, et al. Heart transplantation an answer for end-stage heart failure. Crit Care Nurs Clin North Am 2003;15:489-494 (Pubitemid 38609505)
40. Chen JM, Davies RR, Mital SR, et al. Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann Thorac Surg 2004;78:1352-1361